research Nail involvement in patients with moderate-to-severe alopecia areata treated with oral tofacitinib
This study found that oral tofacitinib monotherapy improved nail changes in 73.3% of adults with moderate-to-severe alopecia areata over a median period of 5 months, but nail improvement was not linked to the severity of hair loss or hair regrowth.



